Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

CUSIP: 48576U106

Q3 2023 13F Holders as of 30 Sep 2023

Holder snapshot 7 facts
Share change
-5,430,574
Put/Call ratio
29%
Reported price per share
$1.34
Number of holders
117
Value change
-$10,719,386
Number of buys
55
Number of sells
62
Security identity 1 fact
Shares outstanding
22,658,403

Security key

48576U106

Report period

Q3 2023

Institutions

117

Top holders

10

Ownership snapshot

Top reported holders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BlackRock Finance, Inc.
13D/G signal
Evidence rows
15
Latest as of
30 Jun 2023
13F Lead comparable stake: 51% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
51%
$20,651,735
11,537,281 shares
30 Jun 2023
VANGUARD GROUP INC
13F
Company
13F
38%
$15,544,589
8,684,128 shares
30 Jun 2023
Avidity Partners Management LP
13F
Company
13F
37%
$14,982,479
8,370,100 shares
30 Jun 2023
Palo Alto Investors LP
13F
Company
13F
25%
$10,159,818
5,675,876 shares
30 Jun 2023
CITADEL ADVISORS LLC
13F
Company
13F
14%
$5,637,931
3,149,682 shares
30 Jun 2023
MARSHALL WACE, LLP
13F
Company
13F
11%
$4,374,755
2,443,997 shares
30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
117
Shares
76,219,647
Rows available
117
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
133
Q3 2023 holders
117
Holder diff
-16
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .